Sanctuary Advisors LLC Makes New Investment in Aveanna Healthcare Holdings Inc. $AVAH

Sanctuary Advisors LLC acquired a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 214,153 shares of the company’s stock, valued at approximately $1,835,000.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. grew its holdings in Aveanna Healthcare by 38.0% in the 4th quarter. Vanguard Group Inc. now owns 5,577,010 shares of the company’s stock valued at $45,564,000 after buying an additional 1,535,351 shares during the period. Dimensional Fund Advisors LP grew its holdings in Aveanna Healthcare by 49.5% in the first quarter. Dimensional Fund Advisors LP now owns 1,334,374 shares of the company’s stock valued at $8,593,000 after purchasing an additional 441,707 shares during the period. Segall Bryant & Hamill LLC increased its position in Aveanna Healthcare by 425.8% during the first quarter. Segall Bryant & Hamill LLC now owns 163,966 shares of the company’s stock worth $1,056,000 after purchasing an additional 132,779 shares during the last quarter. NFJ Investment Group LLC purchased a new position in Aveanna Healthcare during the second quarter worth approximately $2,682,000. Finally, Weiss Asset Management LP acquired a new position in shares of Aveanna Healthcare in the 1st quarter valued at $732,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Insider Transactions at Aveanna Healthcare

In other news, major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of the business’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $143,704,885.50. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, major shareholder Robert M. Williams, Jr. sold 14,500,002 shares of the company’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $166,750,023.00. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 79,746,745 shares of company stock valued at $773,117,091. Corporate insiders own 5.30% of the company’s stock.

Analyst Ratings Changes

AVAH has been the subject of a number of research analyst reports. Royal Bank Of Canada upped their price objective on Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a report on Monday. Truist Financial upped their price target on Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a research note on Monday. Barclays boosted their target price on Aveanna Healthcare from $9.00 to $9.50 and gave the stock an “overweight” rating in a report on Thursday, July 9th. Stephens raised shares of Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $10.00 to $11.00 in a research report on Friday, May 15th. Finally, BMO Capital Markets raised their price target on shares of Aveanna Healthcare from $10.00 to $14.00 and gave the company an “outperform” rating in a report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Aveanna Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $12.89.

Aveanna Healthcare Price Performance

AVAH stock opened at $13.62 on Thursday. The firm has a market cap of $2.97 billion, a P/E ratio of 11.07, a price-to-earnings-growth ratio of 0.85 and a beta of 1.90. The company has a debt-to-equity ratio of 4.47, a quick ratio of 1.16 and a current ratio of 1.16. Aveanna Healthcare Holdings Inc. has a 1 year low of $5.93 and a 1 year high of $13.98. The stock has a 50-day simple moving average of $9.95 and a 200-day simple moving average of $8.03.

Aveanna Healthcare (NASDAQ:AVAH) last released its quarterly earnings results on Thursday, August 13th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.17 by $0.05. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%.The firm had revenue of $670.48 million for the quarter, compared to analyst estimates of $638.61 million. On average, equities analysts predict that Aveanna Healthcare Holdings Inc. will post 0.75 earnings per share for the current fiscal year.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.